Novasenta

Pittsburgh, United States

Novasenta develops treatments to transform the lives of patients with cancer.

$15.0M raised

Feb 2024

Venture - Series Unknown

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Novasenta raised?

Novasenta has raised $15.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2024.

Who are Novasenta's investors?

Novasenta's investors include UPMC Enterprises.

Where is Novasenta headquartered?

Novasenta is headquartered in Pittsburgh, United States.

What does Novasenta do?

Novasenta develops treatments to transform the lives of patients with cancer.

What stage is Novasenta at?

Novasenta is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 5, 2024.

MLA

"Novasenta — Funding & Investors." VCBacked, February 5, 2024, https://www.vcbacked.co/company/novasenta. Accessed July 2, 2026.

APA

VCBacked. (2024). Novasenta — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/novasenta

Wikipedia (cite web)

{{cite web |title=Novasenta — Funding & Investors |url=https://www.vcbacked.co/company/novasenta |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 5, 2024.